An international team led by researchers at the Koch Institute, the Broad Institute, Dana-Farber Cancer Institute, and the National Cancer Institute has created nearly 700 well-documented patient-derived cancer models representing 25 cancer types.Senior author Jesse Boehm contributed to the decade-long Human Cancer Models Initiative, which created mostly organoid models that could help researchers identify new drug targets and test potential treatments for a broader range of cancers.